FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BOTCHKAREV, V. A.
Right arrow Articles by PAUS, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BOTCHKAREV, V. A.
Right arrow Articles by PAUS, R.
(The FASEB Journal. 1999;13:395-410.)
© 1999 FASEB


RESEARCH COMMUNICATION

A new role for neurotrophins: involvement of brain-derived neurotrophic factor and neurotrophin-4 in hair cycle control

VLADIMIR A. BOTCHKAREVa , NATALIA V. BOTCHKAREVAa , PIA WELKERa , MARTIN METZa , GARY R. LEWINc , ARUN SUBRAMANIAMe , SILVIA BULFONE-PAUSd , EVELIN HAGENa , ARMIN BRAUNb , MAREK LOMMATZSCHb , HARALD RENZb and RALF PAUSa , 1


a Department of Dermatology, Charité, and

b Institute of Laboratory Medicine, Charité, Campus Virchow Clinic, Humboldt University, Berlin, D-10117, Germany;

c Growth Factor and Regeneration Group, Max-Delbrück Center for Molecular Medicine, Berlin, D-13122 Germany;

d Institute of Immunology, Free University, Berlin, D-12203, Germany; and

e Hoechst Marion Roussel Inc., Bridgewater, New Jersey 08807, USA


   ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Neurotrophins exert many biological effects not directly targeted at neurons, including modulation of keratinocyte proliferation and apoptosis in vitro. Here we exploit the cyclic growth and regression activity of the murine hair follicle to explore potential nonneuronal functions of neurotrophins in the skin, and analyze the follicular expression and hair growth-modulatory function of BDNF, NT-4, and their high-affinity receptor, TrkB. The cutaneous expression of BDNF and NT-4 mRNA was strikingly hair cycle dependent and peaked during the spontaneous, apoptosis-driven hair follicle regression (catagen). During catagen, BDNF mRNA and immunoreactivity, as well as NT-4-immunoreactivity, were expressed in the regressing hair follicle compartments, whereas TrkB mRNA and immunoreactivity were seen in dermal papilla fibroblasts, epithelial strand, and hair germ. BDNF or NT-4 knockout mice showed significant catagen retardation, whereas BDNF-overexpressing mice displayed acceleration of catagen and significant shortening of hair length. Finally, BDNF and NT-4 accelerated catagen development in murine skin organ culture. Together, our data suggest that BDNF and NT-4 play a previously unrecognized role in skin physiology as agents of hair growth control. Thus, TrkB agonists and antagonists deserve exploration as novel hair growth-modulatory drugs for the management of common hair growth disorders.—Botchkarev, V. A., Botchkareva, N. V., Welker, P., Metz, M., Lewin, G. R., Subramaniam, A., Bulfone-Paus, S., Hagen, E., Braun, A., Lommatzsch, M., Renz, H., Paus, R. A new role for neurotrophins: involvement of brain-derived neurotrophic factor and neurotrophin-4 in hair cycle control.


Key Words: BDNF • NT-4 • TrkB • p75NTR • catagen


   INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
INCREASING EVIDENCE SUGGESTS that neurotrophins (NTs)2 also display important nonneuronal functions and are involved, e.g., in regulating the morphogenesis and physiology of several nonneuronal organs 1-6) . In skin, nerve growth factor (NGF) controls not only the development of sensory and autonomic target innervation (7 , 8 ), but also stimulates keratinocyte (KC) proliferation and suppresses KC apoptosis (9–12). Neurotrophins are involved in the control of hair follicle (HF) morphogenesis, a process characterized by tightly choreographed KC proliferation, apoptosis, and differentiation 13-16) , since NGF knockout mice reportedly show retarded hair growth (7) and because neurotrophin-3 (NT-3) -overexpressing and knockout (+/-) mice display alterations in HF development (17) .

In the present study, we have explored nonneuronal functions of brain-derived neurotrophic factor (BDNF) and neurotrophin-4 (NT-4), two members of the neurotrophin family. These basic proteins exert their biological effects via the high-affinity tyrosine kinase receptor TrkB and the low-affinity p75 neurotrophin receptor (p75NTR) 18-26) . BDNF has become recognized for its critical role in the development of the sensory nervous system: for example, BDNF knockout (-/-) mice are characterized by selective sensory disorders and display a reduced number of neurons in sensory ganglia (27 , 28 ), whereas target-derived BDNF is responsible for the development of different subsets of skin nerve fibers 29-31) and for the function of cutaneous mechanoreceptors (32 , 33 ). In contrast to BDNF null animals, which do not survive longer than 3–4 wk after birth (27 , 28 ), NT-4 knockout mice are viable and fertile. They display a 50% neuron loss in the nodose-petrosal and geniculate ganglia, but lose all D-hair afferent neurons that innervate down hairs in the skin 34-37) . In mouse facial skin, NT-4 plays a suppressive role for the formation of free nerve endings in the epidermis (30) .

In embryonic rat skin, BDNF mRNA expression has been reported in the mesenchymal cells of developing vibrissa HF, and NT-4 mRNA was seen in the HF epithelium (38 , 39 ). The beginning of HF morphogenesis in rat embryos coincides with the presence of high levels of cutaneous BDNF and NT-4 mRNA (40) . In adolescent rat skin, BDNF mRNA expression was found in fibroblasts (41) , whereas TrkB-like immunoreactivity (IR) was reported in epidermal KCs of human skin (42 , 43 ). Together, this suggested that BDNF and NT-4 may have additional functions in normal skin physiology that go beyond their recognized roles in the development and normal function of skin innervation and cutaneous sensory organs.

Here we have exploited the HF, a prototypical neuroectodermal–mesenchymal interaction system, as a particularly instructive model for dissecting the general role of BDNF and NT-4 in epithelial tissue remodeling (44 , 45 ). Studying the murine hair cycle with its highly synchronized, rhythmic transformations between stages of resting (telogen), growth (anagen), and apoptosis-driven regression (catagen) (44 , 46 ), the distribution and expression levels of BDNF, NT-4, and TrkB in back skin of adolescent C57BL/6 mice was analyzed by semiquantitative reverse transcriptase-polymerase chain reaction (RT-PCR), in situ hybridization, and/or immunohistology during various stages of the depilation-induced hair cycle (47) . Next, spontaneous HF cycling in infantile BDNF-knockout mice (28) , BDNF-overexpressing mice [A. Subramaniam et al. (1997) Am. J. Resp. Crit. Care Med., Vol. 155, p. A484 (abstr.)], and adolescent NT-4 knockout mice (35) was compared by quantitative histomorphometry to that of corresponding, age-matched wild-type mice. Finally, the effects of BDNF and NT-4 on HF cycling in situ were studied, using a modification of established skin organ culture techniques (10 , 48 ). Using these mouse models, we present the first evidence that BDNF and NT-4 are indeed involved in the control of HF cycling.


   MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Animal models and tissue collection
C57BL/6 mice were purchased from Charles River (Sulzfeld, Germany) and housed in community cages at the animal facilities of the Charité (Virchow Campus, Berlin). BDNF and NT-4 knockout (-/-) mice were housed at the animal facilities of the Max-Delbrück Center for Molecular Medicine Berlin-Buch. BDNF-overexpressing mice were housed at the animal facility of the Benjamin Franklin University Medical Center (Free University, Berlin). All mice were fed water and mouse chow ad libitum and kept under 12 h light/dark cycles.

BDNF and NT-4 knockout mice were generated using conventional gene targeting techniques (28 , 35 ) and were obtained from the corresponding laboratories. Genotyping of mutant animals was performed using PCR protocols for the mutated alleles and slot blot analysis of isolated tail DNA (49) . BDNF knockout (-/-) mice show vestibular abnormalities and die within 22–23 days after birth (28) , whereas NT-4 knockout mice are viable and fertile (35) . BDNF-overexpressing transgenic mice were generated using the {alpha}-myosin heavy chain as promoter [A. Subramaniam et al. (1997) Am. J. Resp. Crit. Care Med., Vol. 155, p. A484 (abstr.)], which ensures strong expression of BDNF in heart, lung, and skeletal muscles (50 , 51 ). These transgenic mice are characterized by the ectopic expression of BDNF mRNA in the panniculus carnosus muscle in murine subcutis and display an almost threefold increase in the steady-state levels of BDNF protein in back skin, as determined by enzyme-linked immunoassay (ELISA) (31) . BDNF and NT-4 knockout as well as BDNF-overexpressing mice display no obvious macroscopic hair growth abnormalities.

Active hair growth (anagen) was induced as previously described (47) in the back skin of 6- to 9-wk-old C57BL/6 female mice or in 8-wk-old NT-4 knockout (-/-) and their corresponding age-matched wild-type mice in the telogen phase of the hair cycle. In C57BL/6 mice, all key hair cycle stages (52) were studied, using at least five mice per time point: telogen (untreated skin); anagen II-VI [3–12 days after anagen induction by depilation (p.d.)]; and catagen (17–19 days p.d.) (47 , 53 ). In adolescent NT-4 knockout and corresponding wild-type mice, only the catagen stage (day 19 p.d.) of the induced hair cycle (53) was studied; four mice of each strain were analyzed.

To the analyze spontaneous hair follicle cycling in infantile BDNF knockout (-/-), BDNF-overexpressing, and corresponding age-matched, wild-type mice, skin was harvested 16–23 days after birth (P16–P23: postnatal days 16–23) and four to seven mice of each strain were analyzed. In all experiments, the neck region of the back skin was harvested parallel to the vertebral line and was embedded by using a special technique for obtaining longitudinal cryosections through the HFs from one defined site (54) .

RT-PCR
Total RNA was isolated from full thickness back skin samples (homogenized in liquid nitrogen), using a single-step guanidine thiocyanate-phenol-chloroform methodwith the RNeasy-total-RNA-kit (Quiagen, Hilden, Germany). Skin samples included the subcutaneous skeletal muscle layer (panniculus carnosus). cDNA was synthesized by reverse transcription of 3 µg total RNA, using a cDNA synthesis kit (Invitrogen, San Diego, Calif.). The following sets of oligonucleotide primers were used to amplify specific cDNA: ß-actin: 5'-GAA AAC GCA GCT CAG TAA CAG TCC G and 5'-TAA AAC GCA GCT CAG TAA CAG TCC G-3'; BDNF: 5'-GTG AGA AGC TTG ATG ACC ATC C and 5'-AAC AGA ATT CCA CTA TCT TCC C (55) ; NT-4: 5'-CCC TGC GTC AGT ACT TCT TCG AGA C and 5'-CTG GAC GTC AGG CAC GGC CTG TTC (56) . Amplification was performed using taq polymerase (Gibco, Grand Island, N.Y.) over 24–34 cycles, using an automated thermal cycler (Perkin Elmer Cetus, Norwalk, Conn.). Each cycle consisted of the following steps: denaturing at 94°C (1 min), annealing at 60°C (45 s), and extension at 72°C (45 s). PCR products were analyzed by gel electrophoresis (2% agarose) and enzymatic digestion using standard methods (57 , 58 ). For semiquantitative RT-PCR, linear correlation of signal intensity for ß-actin was found between 24 and 27 cycles, and for the other markers, between 30 and 35 cycles, using a video scanner system Scan Pack 2.0 (Biometra, Göttingen, Germany). This allowed for the demonstration of clearly different signals as compared to control signals.

In situ hybridization
In situ hybridization (ISH) was carried out on mouse skin, as described (59) , with the following modifications. Cryostat sections (8 µm) of paraformaldehyde-fixed skin were placed on RNAse-free gelatin-coated slides and hybridized with a digoxigenin-labeled synthetic riboprobe (labeled at the 3'-end with Dig-dUTP) that is complementary to bases 224-734 of the BDNF gene (60) . ISH was performed at 60°C for 17 h with 160 µl of hybridization buffer containing 50% formamide, 4xSSC, and 150 ng/ml of riboprobe. After hybridization, the slides were washed first in 2xSSC at 69°C for 1 h, then in 0.1xSSC at 69°C for 1 h. After washing, slides were incubated with alkaline phosphatase-conjugated anti-digoxigenin antibody (Boehringer-Mannheim, Mannheim, Germany; 3 h, room temperature) and processed for reaction product development, as described (59) . Incubation of sections with ribonuclease or correspondent sense probe, as well as skin sections from BDNF knockout mice (-/-), were used as negative controls; cryosections from the heart of BDNF-overexpressing mice were used as positive controls. These controls confirmed the specificity and sensitivity of the used ISH methodology.

For analysis of TrkB mRNA, ISH was carried out according to a protocol that had been adapted for oligonucleotide probes complementary to NT and NT receptor mRNAs (17 , 61 ), using the following modifications. Cryostat sections (8 µm) were hybridized with the commercially available synthetic oligonucleotide probes complementary to bases 716-745 (62) of full-length rat TrkB (Biognostic, Göttingen, Germany), labeled at the 3'-end with TRITC-dUTP (Boehringer-Mannheim) using terminal deoxynucleotidyl transferase (TdT, Promega, Madison, Wis.). ISH was performed at 30°C for 16 h with 60 µl of hybridization buffer (Biognostic) containing 50% formamide, 4xSSC, and 10 pmol/ml of oligonucleotide probe. After hybridization, the slides were first washed in 1xSSC 5 min at room temperature, then in 0.1xSSC (4 changes, 15 min each) at 35°C. After washing, slides were rinsed rapidly in deionized water, mounted into Vectashield medium (Vector, Burlingame, Calif.), and examined under a Zeiss Axioscope fluorescence microscope. Hybridization specificity was controlled by the pretreatment of sections with ribonuclease A (100 µg/ml, 1 h at 37°C) as well as by abrogation of the hybridization signal by the addition of 100 pmol/ml of unlabeled oligonucleotide to the TRITC-labeled probe (negative controls). Cryostat sections of embryonic brain with their strong TrkB transcript signals served as positive controls. All controls yielded the expected negative or positive results, documenting hybridization specificity.

Immunohistochemistry
Incubation of cryostat sections of skin either with rabbit antisera against BDNF, NT-4, TrkB, or chicken antisera against BDNF, NT-4 (see Table 1 ), followed by TRITC-conjugated F(ab)2 fragments of a goat anti-rabbit immunoglobulin G (IgG) (Jackson ImmunoResearch, West Grove, Pa.) or a rabbit-anti-chicken Ig (Sigma, St. Louis, Mo.), was performed as described 63-65) . For all antisera, incubation of skin sections without primary antisera and cryostat sections of embryonic brain were used as negative and positive controls, respectively. For all antisera, preabsorption of primary antisera with 100 µg/ml of corresponding antigenic peptides (37°C, 60 min) was used as an additional negative control.


View this table:
[in this window]
[in a new window]
 
Table 1. Primary antibodies

For double immunodetection of TrkB- or PGP9.5 (pan-neuronal marker) -IR or BDNF- and NT-4-IR, the tyramide amplification method was used, which had been developed for the simultaneous immunofluorescence determination of two antigens with antisera obtained from the same species (66) . Briefly, after blocking of endogenous peroxidase and nonspecific avidin/biotin binding, sections were incubated in TNB buffer (0.1 M Tris-HCl, pH 7.5, 0.15 M NaCl, and 0.5% DuPont Blocking Reagent, DuPont NEN, Boston, Mass.) for 30 min. Next, rabbit antisera against TrkB (1:1000) or PGP9.5 (1:10000) were applied overnight. At this dilution, antigen–antibody complexes were undetectable for the fluorochrome-labeled secondary goat anti-rabbit antiserum, but became visible when using biotinylated goat anti-rabbit antiserum, diluted in TNB blocking buffer (DuPont NEN; 1:200, 30 min), and the tyramide amplification kit (DuPont NEN). Subsequently, sections were incubated in streptavidin-horseradish peroxidase (1:100 in TNB, 30 min). Three washes with TNT buffer (0.1 M Tris-HCl, pH 7.6, 0.15M NaCl, 0.05% Tween) were followed by a 10 min application of TRITC-tyramide (1:50 in Amplification Diluent, Du Pont NEN). After blocking nonspecific binding with 10% normal goat serum, sections were incubated with rabbit antisera against BDNF or NT-4 (1:50, overnight, room temperature), washed in TBS (3x5 min), followed by incubation with Cy2-conjugated goat anti-rabbit secondary antibody (Jackson ImmunoResearch; 1:20, 37°C, 1 h). Finally, sections were washed three times with Tris buffer and counterstained with Hoechst 33342 for identification of cell nuclei (46 , 67 ).

For the double immunovisualization of p75NTR- or Bcl-2-IR on the one hand, and TrkB-IR on the other, monoclonal antibodies against mouse p75NTR or Bcl-2 (Table 1) were used and the tyramide amplification method was applied for their visualization (see above), using biotinylated goat-anti-rat or goat-anti-hamster IgG, streptavidin-horseradish peroxidase, and TRITC-tyramide. Immunovisualization of TrkB-IR was performed using Cy2-conjugated goat anti-rabbit secondary antibody, as described above. All sections were examined under a Zeiss Axioscope microscope and photodocumented with the help of a digital image analysis system (ISIS MetaSystem, Altlussheim, Germany).

Double immunodetection of TUNEL-positive cells and TrkB-IR
To detect apoptotic cells, we used an established, commercially available TUNEL kit (ApopTag, Oncor, Gaithersburg, Md.) as described (46 , 67 ). For double immunofluorescence detection of TUNEL-positive cells and TrkB-IR, sections were incubated with digoxigenin-dUTP in the presence of TdT, followed by incubation with rabbit-anti-TrkB antiserum. Subsequently, TUNEL-positive cells were visualized by anti-digoxigenin FITC-conjugated F(ab)2 fragments. TrkB-IR was detected by goat anti-rabbit TRITC-conjugated antibody, and sections were counterstained with Hoechst 33342 (46) . Negative controls for TUNEL staining were made by omitting TdT, according to the manufacturer's protocol. Positive TUNEL controls were run in comparison with tissue sections from the thymus of young mice, which display a high degree of spontaneous thymocyte apoptosis (46 , 67 ).

Skin organ culture
Punch biopsies (4 mm) were prepared under sterile conditions from adolescent C57BL/6 mouse back skin with all HFs in the late anagen VI to early catagen stage of the induced hair cycle [i.e., day 17 after depilation (53) ], following previously described protocols (10 , 48 ) with some modifications. For each experimental group, eight to ten randomized skin punches, derived from the back skin of three different mice, were placed (dermis down) on prehydrated gelatin sponges (Gelfoam, Upjohn Co., Kalamazoo, Mich.) in 35 mm petri dishes containing 5 ml Dulbecco's modified Eagle's medium, 10% fetal bovine serum, 50 mg/ml L-glutamine, and antibiotic/antimycotic mixture (Gibco). After addition of 0.5–50 ng/ml human recombinant BDNF or NT-4 (Promega), organ cultures were incubated at the air–liquid interphase for 48 h at 37°C in 5% CO2, and 100% humidity. At the end of incubation, all skin fragments were washed repeatedly in phosphate-buffered saline buffer at 4°C, fixed in 4% paraformaldehyde, and embedded in paraffin for routine histology and histomorphometry.

Histomorphometry and statistical analysis
In adolescent skin, IR patterns were examined by studying at least 50 different HFs per mouse; five mice were assessed per hair cycle stage. For each stage of HF cycling, the major IR patterns were recorded in previously prepared, computer-generated schematic representations of murine HF cycling that allow a standardized, easily reproducible, and systematic comparison of different follicular IR patterns (68) . For precise identification of defined stages of HF cycling, histochemical detection of endogenous alkaline phosphatase activity was used since it allows one to visualize the morphology of the dermal papilla as a useful morphological marker for staging HF cycling (69) .

The percentage of HFs in different stages of growth (anagen), regression (catagen), or resting (telogen) was assessed and calculated in BDNF-overexpressing and BDNF knockout (-/-) mice at P16 and P22, respectively, as well as in their corresponding age-matched wild-type littermates. During these days of postnatal development, the hair follicle, after completion of morphogenesis, begins its lifelong cycle of regression, resting, and growth by spontaneous entry into the first catagen stage (44 , 68 ). In normally cycling mice, this occurs around P17, and at P20–22 all hair follicles in back skin reach the resting stage of the hair cycle (telogen).

In adolescent NT-4 knockout (-/-) and corresponding wild-type mice, the percentage of hair follicles in different stages of catagen development was calculated on day 19 of the depilation-induced hair cycle (47 , 53 ). All evaluations were performed on the basis of accepted, well-defined morphologic criteria of HF classification (13 , 44 , 52 , 53 , 68-71 ). Only every tenth cryosection was used for analysis in order to exclude the repetitive evaluation of the same HF, and 2–3 cryosections were assessed from each animal. Altogether, 200–350 follicles in 50–60 microscopic fields, derived from four to seven animals (approximately 50–60 follicles per animal), were analyzed and compared to a corresponding number of HF from the appropriate, age-matched wild-type mice. In skin organ culture, the percentage of HFs in defined catagen stages was calculated in 8–10 biopsies per group at magnification x400 under a Zeiss Axioscope microscope, following accepted morphological criteria for the classification of defined stages of catagen development (53 , 69-71 ). All sections were analyzed at x200 magnification.

For the assessment of hair shaft length, hairs were plucked from the back skin of BDNF-overexpressing (n=8) and wild-type mice (n=4) at P22, i.e., in the telogen phase of the hair cycle. Hair length was measured as a distance from the proximal part of club hair to hair tip (10 hairs were analyzed from each animal) as assessed under x40 of Zeiss Axioscope microscope using a digital image analysis system (ISIS MetaSystem). The length of these hair shafts is directly proportional to the duration of active hair generation during the final stages of HF morphogenesis, and thus reflects the time point when hair shaft production is switched off by entry into the first catagen stage.

Means and SEM were calculated from pooled data. Differences were judged as significant if the P value was lower than 0.05, as determined by the independent Student's t test for unpaired samples.


   RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
BDNF and NT-4 gene expression in normal mouse skin are hair cycle dependent and peak toward or during hair follicle regression
As an important phenomenological indicator for a possible involvement of BDNF/NT-4-related signaling in hair growth control, BDNF and NT-4 gene transcription in full-thickness adolescent mouse skin was characterized by semiquantitative RT-PCR analysis during the induced, highly synchronized murine hair cycle. Whereas BDNF transcripts were not detectable in mouse skin with all HFs in the resting stage (telogen skin; Fig. 1A, C ), very low steady-state levels of BDNF mRNA first appeared when all HFs had reached the late growth stage of the hair cycle (anagen VI, day 12 after depilation, Fig. 1C ). Maximal steady-state levels of BDNF transcripts were detected in skin, with all HFs entering spontaneously into the regression stage of the hair cycle (catagen; days 17–19 after depilation). At the end of the hair cycle, BDNF mRNA levels again declined toward telogen levels (Fig. 1A, C ).



View larger version (28K):
[in this window]
[in a new window]
 
Figure 1. Semiquantitative RT-PCR analysis of BDNF and NT-4 transcripts during the depilation-induced hair cycle. A) mRNA steady-state levels during the induced hair cycle. At the defined time points, total RNA from full-thickness skin of C57BL/6 mice was extracted and reverse transcribed. A semiquantitative RT-PCR using primers specific for ß-actin, BDNF, or NT-4 was performed. A) Representative gels from one of three experiments [days 0 and 25, resting stage (telogen); days 1–12, active hair growth stage (anagen); days 17–19, HF regression stage (catagen)]. B–D) densitometric analysis of RT-PCR signals specific for ß-actin (B), BDNF (C), and NT-4 (D) (means±SEM of n=3); *P < 0.05, **P < 0.01, ***P < 0.001. X-axis: days after anagen induction by depilation. The corresponding hair cycle stages are indicated at the top of panel A.

In contrast, NT-4 mRNA was present in telogen skin, and steady-state levels increased progressively from telogen to late anagen, peaking during late anagen and anagen-catagen transformation of the HF (days 12–18 after depilation, Fig. 1A, D ). During the development of catagen and the subsequent transformation to telogen (day 25 after depilation), NT-4 gene expression significantly declined again compared with late anagen levels (Fig. 1A, D ). Together, these transcription data are compatible with the concept that both BDNF and NT-4 gene expression is regulated in a hair cycle-dependent manner and that they may be specifically involved in the control of HF transformation from active growth (anagen) to regression (catagen).

Hair follicle expression of BDNF and NT-4 is up-regulated during catagen
To correlate BDNF and NT-4 gene expression in full thickness skin with the intrafollicular expression patterns of BDNF and NT-4 in situ during different stages of HF cycling, in situ hybridization of BDNF mRNA and immunohistochemistry for BDNF and NT-4 antigen expression were assessed in the back skin of adolescent C57BL/6 mice. BDNF- and NT-4-IR patterns were each assessed with two distinct antisera (Table 1) , since antibody specificity in discriminating between members of the neurotrophin family may be unsatisfactory (61) . However, both antisera gave very similar results in all staining protocols as well as in the positive and negative control experiments (not shown), thus attesting to the specificity and sensitivity of our immunohistological detection techniques. For more extensive analyses, we selected an antiserum against amino acids 128-147 mapping at the carboxy terminus of the human BDNF (which is fully homologous to the corresponding mouse sequence) and an antiserum against amino acids 80-99 mapping at the amino terminus of the NT-4 precursor (3) because they provided the best signal/noise ratio. The observed expression patterns of BDNF- and NT-4-IR are documented by the representative examples in Fig. 2 and are schematically summarized in Fig. 3 .



View larger version (100K):
[in this window]
[in a new window]
 
Figure 2. Hair follicle-associated BDNF mRNA as well as BDNF and NT-4 antigen expression are hair cycle-dependent. Cryostat sections (8 µm thickness) of adolescent C57BL/6 murine back skin in the defined hair cycle stages [telogen = unmanipulated skin (day 0), anagen VI = 8–12 days after anagen induction by depilation, catagen II-VI = 17–19 days after anagen induction] were processed for BDNF mRNA detection by in situ hybridization or stained with antisera against BDNF or NT-4 (cf. Table 1 ). Figure 3 provides a schematic summary of the immunoreactivity results shown here. A–C) In telogen skin, no BDNF mRNA was found in skin (A), whereas BDNF-IR (B, arrow) was found in dermal nerve bundles and NT-4-IR was seen in single outer root sheath KCs (C, arrows). In panels A, B, the hair follicle is indicated by a dotted line. D–F) In anagen VI, BDNF mRNA (D), BDNF- (E), and NT-4-IR (F) were observed in the proximal outer root sheath (D–F, arrows) and the proximal hair matrix (D–F, small arrowheads). In addition, NT-4-IR was seen in proximal IRS (F, large arrowheads). G–I) In catagen II, most KCs of the outer root sheath (G–I, arrows), IRS (G–I, large arrowheads), and hair matrix (G, H, small arrowheads) showed enhanced levels of BDNF mRNA(G) as well as BDNF- (H) and NT-4-IR (I). J–L) In catagen VI, BDNF mRNA and IR were located in KCs of the secondary hair germ (J, K, arrows) and the ORS (J, K, large arrowheads). NT-4-IR was very prominently expressed by single cells in the regressing epithelial strand (L, arrows). Note that the apparently `nuclear' NT-4-IR pattern seen in panel L is an artifact resulting from the exposition time required for photodocumenting both the NT-4-IR and anatomical hair follicle details (in fact, NT-4-IR is clearly cytoplasmic; cf. Fig. 4H ). M) Sense control for BDNF mRNA in situ hybridization (proximal hair bulbs are indicated by arrowheads). N, O) Negative controls for antisera against BDNF (N) and NT-4 (O). Abbreviations: DP, dermal papilla; EP, epidermis; ES, epithelial strand; IRS, inner root sheath; HF, hair follicle; HM, hair matrix; HS, hair shaft; Mel, melanin; ORS, outer root sheath; PCM, panniculus carnosus muscle; SC, subcutis; SHG, secondary hair germ. Scale bar: A–L, N, O: 50 µm; M: 100 µm.



View larger version (37K):
[in this window]
[in a new window]
 
Figure 3. Schematic representation of BDNF-, NT-4-, and TrkB-IR during the adolescent C57BL/6 murine hair cycle. A) Cell populations with TrkB-IR expression are depicted as open circles; those with BDNF-IR are shown in grey, and colocalization of BDNF- and TrkB-IR is indicated in black. B) Cell populations with NT-4-IR expression are indicated in grey, and colocalization of NT-4- and TrkB-IR is shown in black. Different stages of the hair cycle are indicated according to Chase (52) , with modifications (68) . The summary schemes were derived from analyzing >50 longitudinally sectioned follicles from the lower back of 5 C57BL/6 mice harvested per time point. Abbreviations: APM, arrector pili muscle, DP, dermal papilla; E, epidermis; ES, epithelial strand; HM, hair matrix; HS, hair shaft; IRS and ORS, inner and outer root sheath; SG, sebaceous gland; SHG, secondary hair germ.

In line with our RT-PCR results (Fig. 1A, C ), no expression of BDNF mRNA was found in telogen HFs (Fig. 2A ), whereas the only signal indicating the presence of BDNF was observed in dermal nerve bundles of telogen skin, which showed strong BDNF-IR (Fig. 2B ). Double immunovisualization of PGP9.5- and BDNF-IR confirmed the BDNF-positive structures shown in Fig. 2B to nerve fibers (not shown). In telogen epidermis, the BDNF mRNA signal was not above background levels (Fig. 2A ), which is consistent with RT-PCR data (Fig. 1A, C ). KCs in the outer root sheath (ORS) of the HF were weakly NT-4-IR in telogen skin (Fig. 2C ). During early and middle anagen, NT-4-IR was seen in single ORS KCs, but no expression of BDNF mRNA and IR was found (Fig. 3) . During progressing anagen development, BDNF mRNA and BDNF-IR appeared in the proximal ORS and hair matrix of anagen VI HFs (Fig. 2D, E ), which corresponds well to the RT-PCR results (Fig. 1A, C ). NT-4-IR was present not only in hair matrix KCs and the proximal ORS, but also in the inner root sheath (IRS) of anagen VI HFs (Fig. 2F ).

A marked enhancement of BDNF mRNA expression in situ, as well as of BDNF- and NT-4-IR, was noted in proximal hair matrix, ORS, and IRS KCs when the HF entered spontaneously into the early steps of regression (53 , 70 ) (catagen II, Fig. 2G–I ). During later stages of HF regression (catagen VI), KCs of the so-called secondary hair germ and ORS expressed BDNF mRNA and maximal BDNF-IR (Fig. 2J, K ), whereas isolated KCs in the regressing epithelial strand were maximally NT-4-IR (Fig. 2L ). The dermal papilla of murine HF never showed BDNF mRNA-related signals above background, BDNF-, or NT-4-IR at any time during the hair cycle. Sensitivity and specificity of our in situ hybridization and immunohistology protocols were confirmed as described in Materials and Methods and as clearly shown in Fig. 2M–O .

TrkB is prominently expressed in the dermal papilla and regressing hair follicle epithelium during catagen
To define potential follicular targets for BDNF and NT-4 signaling, whose expression peaked in the regressing HF epithelium during catagen (Fig. 2G–L ), ISH and immunohistochemistry were performed to localize expression of TrkB, the common high-affinity receptor for these neurotrophins, during the anagen-catagen transition. Also, double immunostaining was performed to covisualize the expression of TrkB and BDNF or TrkB and NT-4 antigens. Since we had previously defined the follicular IR of the low-affinity neurotrophin receptor p75NTR during the anagen-catagen transformation (46) , coexpression of TrkB and p75NTR was also assessed.

Again, the patterns of TrkB-IR were defined using two different antisera (Table 1) to assure specificity of the staining results. Both antisera yielded very similar staining results (not shown). Furthermore, the patterns of TrkB-IR were compared to those obtained with different antisera against other Trk receptors (full-length forms of TrkA and TrkC, truncated form of TrkB; ref 45 ) that we are using in related studies. Since the latter antibodies demarcated substantially different IR patterns from the ones described here for TrkB (not shown), this further attested to the specificity and sensitivity of our TrkB immunostaining results.

In anagen VI HFs, expression of TrkB mRNA and TrkB antigen was found in the central and proximal ORS (Fig. 3A ; Fig. 4A, B ). During early catagen, TrkB mRNA and protein were observed in hair matrix KCs and dermal papilla fibroblasts (Fig. 3A ; Fig. 4C, D ), which are widely recognized as the mesenchymal key element of hair cycle control (44 , 72 ). During laterstages of catagen development (catagen VI), expression of TrkB mRNA and IR disappeared from the dermal papilla, but became prominent in the epithelial strand and secondary hair germ (Fig. 3A ; Fig. 4E, F ).

During catagen VI, many TrkB-IR cells in the secondary hair germ coexpressed BDNF-IR (Fig. 4G ). TrkB-IR in the epithelial strand was localized closely to NT-4-IR cells, yet no coexpression of TrkB- and NT-4-IR was seen here (Fig. 4H ). Also, a subpopulation of cells in the secondary hair germ coexpressed TrkB-IR and p75NTR, but no such coexpression was found in the epithelial strand (Fig. 4I ).



View larger version (77K):
[in this window]
[in a new window]
 
Figure 4. Expression and coexpression status of TrkB during catagen. Back skin cryostat sections (8 µm thickness) of adolescent C57BL/6 mice in defined hair cycle stages (anagen VI = 12 days after anagen induction by depilation, catagen II-VI = developed spontaneously 17–19 days after anagen induction) were processed for TrkB mRNA detection by in situ hybridization (A, C, E) or stained with antiserum against TrkB (96) (B, D, F). Alternatively, sections were processed for double immunovisualization of TrkB- and BDNF-IR (G), TrkB- and NT-4-IR (H), TrkB- and p75NTR-IR (I), TrkB- and Bcl-2-IR (J), or TrkB- and TUNEL (K). G, H) TrkB-IR is evident as red fluorescence, BDNF- or NT-4-IR as green fluorescence, and TrkB/BDNF or NT-4 double labeling as yellow fluorescence. The sections shown in panels H, I, K were counterstained by Hoechst 33342 for visualization of cell nuclei. A, B) In anagen VI skin, TrkB mRNA (A) and TrkB-IR (B) were seen in central and proximal ORS KCs (arrows). C, D) In catagen II skin, TrkB mRNA (C) and TrkB-IR (D) were expressed in the dermal papilla (arrows) and the proximal ORS (arrowheads). E, F) In catagen VI skin, TrkB mRNA (E), and TrkB-IR (F) were found in the secondary hair germ (arrows) and the epithelial strand (small arrowheads), whereas the dermal papilla was already TrkB negative (large arrowheads). G) TrkB- and BDNF-IR were coexpressed in most KCs of the secondary hair germ (yellow fluorescence, arrows), whereas only the receptor appeared to be expressed in the epithelial strand (red fluorescence, small arrowhead). BDNF-IR was also seen in subcutaneous nerve fibers (green fluorescence, large arrowhead). H) In the epithelial strand, TrkB-IR cells (red fluorescence, arrow) were located next to NT-4-IR KCs (green fluorescence, arrowheads), but double-labeled cells were not apparent. Nuclei are counterstained by Hoechst 33342 (blue fluorescence). I) TrkB- and p75NTR-IR were colocalized in a small population of KCs of the secondary hair germ (yellow fluorescence, arrow). In contrast, KCs of the epithelial strand and ORS were either TrkB+ (green fluorescence, large arrowheads) or p75NTR+ (red fluorescence, small arrowhead). Nuclei are counterstained by Hoechst 33342 (blue fluorescence). J) Numerous cases of colocalization of TrkB- and Bcl-2-IR were seen in the secondary hair germ and the epithelial strand (yellow-orange fluorescence, arrows). Bcl-2 alone (red fluorescence) was strongly expressed in dermal papilla (arrowhead). K) Isolated TrkB-IR cells in the epithelial strand were also TUNEL+ (yellow-orange fluorescence, arrow), although many cells in both epithelial strand and secondary hair germ were either TrkB+ (red fluorescence, large arrowhead) or TUNEL+ (green fluorescence, small arrowhead). Nuclei are counterstained by Hoechst 33342 (blue fluorescence). Inserts in panels H–K show a higher magnification of the corresponding HF compartments. Abbreviations: CH, club hair; DP, dermal papilla; EP, epidermis, ES, epithelial strand, IRS, inner root sheath, HF, hair follicle, HM, hair matrix; HS, hair shaft; ORS, outer root sheath; SHG, secondary hair germ. Scale bars: 50 µm.

Because apoptosis-driven HF regression is associated with characteristic patterns of Bcl-2-IR and TUNEL-positive cells (46) , TrkB-IR, on the one hand, and Bcl-2-IR or TUNEL positivity on the other were also covisualized. During catagen VI, numerous TrkB+ KCs in the secondary hair germ contained Bcl-2-IR nuclei and, in the epithelial strand, TrkB- and Bcl-2-IR also frequently colocalized (Fig. 4J ). In contrast, no coexpression of TrkB-IR and TUNEL was found in the secondary hair germ, and only single TrkB-IR KCs in the epithelial strand displayed TUNEL positivity, whereas most TrkB-IR cells in the epithelial strand were TUNEL negative (Fig. 4K ).

Together, these data suggest that TrkB-related signaling plays a role in the control of apoptosis-driven HF regression. This appears to be in line with recent reports that neurotrophins can both suppress and induce apoptosis in different model systems (cf. 73-80 ). Therefore, we used functional assays in order to further explore the role of BDNF and NT-4 in catagen control.

BDNF and NT-4 knockout mice show catagen retardation whereas BDNF overexpression causes acceleration of catagen and shortening of hair length
To define whether constitutive BDNF or NT-4 deletion or overexpression alter spontaneous catagen development, neonatal BDNF knockout (-/-) and BDNF transgenic mice were compared for the onset and speed of spontaneous HF regression, using age-matched wild-type mice as controls. Spontaneous catagen development was studied both in adolescent NT-4 knockout (-/-) (35) and corresponding wild-type mice during the depilation-induced hair cycle (47) . For precise identification of defined stages of HF cycling, namely, of the anagen-catagen transformation, in addition to well-recognized morphological classification criteria (13 , 46 , 52 , 53 , 68 ), endogenous alkaline phosphatase activity was assessed histochemically, which allows one to visualize changes in the dermal papilla morphology as a useful marker for staging HF cycling (69) .

After the completion of HF morphogenesis (which is often mislabeled as the `first hair cycle'), the hair follicle begins its lifelong cycle of regression, resting, and growth by spontaneous entry into the first catagen stage (14 , 16 , 44 ). In normally cycling mice, this occurs around P17; by P20–P22, most HFs are already in the resting stage of the cycle (telogen) (16) . In BDNF knockout (-/-) mice at P22, many HFs were still in later stages of regression (catagen VI) (Fig. 5 A–C), whereas practically all HFs of wild-type mice were already in the latest stage of catagen or in telogen.



View larger version (42K):
[in this window]
[in a new window]
 
Figure 5. Retardation of hair follicle regression in BDNF knockout (-/-) mice and acceleration of catagen development in transgenic skin. For hair cycle staging, skin cryosections of infantile BDNF knockout (-/-), BDNF-overexpressing, and corresponding age-matched wild-type mice were processed for detection of endogenous alkaline phosphatase activity (69) , and the percentage of HFs in defined catagen stages was evaluated according to well-defined morphologic criteria (53, 69–71). BDNF knockout (-/-) mice (A–C) were studied at P22 (day 22 after birth) and BDNF-overexpressing mice (D–F) at P16, because these were the only time points of the catagen-telogen transformation of the murine hair cycle, where four to seven mutant and wild-type mice were available for quantitative histomorphometry). A–C) Dynamics of hair follicle regression in BDNF knockout mice. Wild-type skin displayed only HFs in the latest catagen and telogen stages at P22 (A, arrows) characterized by their location at the dermis-subcutis border, their shortening to almost telogen length, and a maximally condensed dermal papilla. Compared to wild-type mice, BDNF knockout (-/-) mice displayed a significantly enhanced number of catagen VI HFs (B, arrows; C), whose dermal papilla is still located deep in the subcutis (46 , 53 , 70 ), and a reduced number of catagen VIII HFs (C). D–F) Dynamics of catagen development in BDNF-overexpressing mice. At P16, wild-type animals displayed early catagen HFs (D, arrows) characterized by the presence of an elongated dermal papilla, which is still surrounded by hair matrix KCs (46 , 53 , 70 ). Compared to wild-type mice, BDNF-overexpressing mice at this time showed clear signs of accelerated catagen development, namely, an enhanced number of catagen VI HFs (E, arrows, characterized by disappearance of the hair matrix and marked dermal papilla condensation), and a significantly reduced percentage of catagen I and III HFs (F). In addition, transgenic subcutis was considerably thinner than that of wild-type skin [compare panels D and E, highly suggestive of substantially advanced catagen development (71 , 81 )]. Asterisks in panels C, F indicate significant differences between defined catagen stages in wild-type vs. mutant mice. Student's t test, *P < 0.05; **P < 0.01. Abbreviations: DER, dermis; DP, dermal papilla; EP, epidermis; PCM, panniculus carnosus muscle; SC, subcutis. Scale bars: 100 µm.

Inverse dynamics of catagen development were found in transgenic mice that overexpress BDNF under the {alpha}-myosin heavy chain promoter. These mice are characterized by ectopic expression of BDNF mRNA in the subcutaneous striated muscle layer (panniculus carnosus) and by threefold enhanced levels of BDNF protein in skin extracts, as determined by ELISA (31) . In transgenic skin, many HFs had prematurely entered into advanced stages of catagen development on P16, and a significant decline in the percentage of catagen I and III HFs was found in BDNF-overexpressing mice compared to wild-type skin (Fig. 5F ). This was in contrast to wild-type animals, where most back skin HFs were still in late anagen VI or early catagen (Fig. 5D–F ). Moreover, as a reliable additional indicator of advanced catagen development (47 , 70 , 81 ), transgenic skin was substantially thinner than wild-type skin (Fig. 5D, E ). Hair length in BDNF-overexpressingmice at P22 (7.29±0.4 mm) was also significantly shorter compared to the corresponding age-matched wild-type animals (8.81±0.31 mm, P<0.05), which confirms premature catagen development (i.e., shortening of the hair shaft-producing anagen phase) in BDNF transgenic mice.

Similar to infantile BDNF knockout animals, adolescent NT-4 knockout (-/-) mice also showed retardation of catagen development. On day 19 after depilation, many HFs were still in early or in middle catagen (catagen II-IV); a significant reduction in the number of catagen VI HFs was found compared to wild-type skin (Fig. 6 A–C), where only catagen VI-VIII HFs were seen. For comparison, in normally cycling mice the catagen-telogen transformation is usually completed around day 19 (46 , 53 , 68 , 70 ). Also, skin thickness was substantially higher in NT-4 knockout mice compared to that of wild-type animals, indicating a strong retardation of catagen (81) . These mutational analyses suggest that BDNF and NT-4 are both involved in the control of catagen.



View larger version (60K):
[in this window]
[in a new window]
 
Figure 6. Adolescent NT-4 knockout (-/-) mice show a retardation of catagen development. On day 19 of the induced hair cycle (47) , skin cryosections of four adolescent NT-4 knockout (-/-) and four age-matched wild-type mice were processed and evaluated as before (see Fig. 5 ). Wild-type animals showed almost all HFs to be already in catagen VII-VIII (B, arrows). In contrast, NT-4 (-/-) mice still show many HFs in earlier stages of catagen development (A–C; panel C: large arrowhead, catagen IV; small arrowhead, catagen VI). Compared with NT-4 knockout mice, skin thickness was substantially reduced in wild-type mice, indicating the advanced catagen progression in the latter (71 , 81 ). Asterisks in panel A indicate significant differences between defined catagen stages in wild-type mutant mice. Student's t test, *P < 0.05; **P < 0.01. Abbreviations: EP, epidermis; DER, dermis; PCM, panniculus carnosus muscle; SC, subcutis. Scale bars: 100 µm.

BDNF and NT-4 accelerate catagen development in skin organ culture
To further probe the concept that BDNF and NT-4 are indeed among the few catagen-promoting agents identified so far (14 , 44 , 82 , 83 ), BDNF or NT-4 were added to organ-cultured murine skin, with most HFs in the process of initiating the anagen VI–catagen transformation of the hair cycle. This assay also addressed the problem that alterations in HF cycling observed in BDNF/NT-4 mutant mice in vivo might not necessarily reflect a direct role of these neurotrophins in hair cycle control, but might result from the consequences of neurotrophin overexpression or deletion, such as differences in skin and hair follicle innervation 29-31) . For this purpose, biopsies were taken from normal C57BL/6 mouse skin 17 days after anagen induction by depilation (47) so that skin contained homogeneous, well-defined HF populations about to undergo spontaneous, apoptosis-driven regression (46 , 53 , 70 ) and were devoid of functional innervation or vascular supply. These skin fragments and were cultured at the air–liquid interphase on gelatin gels (`histoculture') (48) for 48 h in the presence or absence of BDNF or NT-4 at concentrations routinely used in neurotrophin studies (0.5–50 ng/ml) (73-75 , 78 , 80 ).

Quantitative histomorphometric analysis (71 , 83 , 84 ) revealed that BDNF or NT-4 treatment each significantly accelerate catagen development in vitro. Compared to vehicle controls, where early catagen HFs (catagen I-III) was dominant (Fig. 7 A), there was a significant increase in the number of HFs in mid-catagen (catagen IV-V) in those skin biopsies that had been cultured in the presence of 0.5 or 5 ng/ml of BDNF. As illustrated by the representative photomicrographs shown in Fig. 7B, C , this acceleration of catagen development corresponded to substantial, easily recognizable morphological differences between control and test biopsies in HF regression in organ culture of intact, normal mouse skin. NT-4 displayed even more potent catagen-promoting activity than BDNF: after incubation with 5 ng/ml of NT-4, some tests HFs were already in catagen VI and a significant increase in the number of catagen IV-V HFs was found (Fig. 7A, D ) compared to vehicle controls. This provides further evidence that BDNF and NT-4 can accelerate spontaneous, apoptosis-driven HF regression even in the absence of functional skin nerves.



View larger version (69K):
[in this window]
[in a new window]
 
Figure 7. BDNF and NT-4 accelerate catagen development in murine skin organ culture. 4 mm punch biopsies taken from C57BL/6 mouse back skin at day 17 of the induced hair cycle (i.e., with all HFs about to enter into the anagen VI-catagen transformation) were incubated at the air–liquid interphase for 48 h in the presence of 0.5–50 ng/ml of BDNF or NT-4, and the percentage of HFs in distinct catagen stages was evaluated by quantitative histomorphometry as described above. A) Percentage of hair follicles at defined catagen stages. Compared to vehicle controls, a significant increase in the percentage of catagen IV-V HFs and a reduction of catagen I-III HFs were seen in skin fragments incubated with 0.5 or 5 ng/ml of BDNF, as well as after incubation with 5 or 50 ng/ml of NT-4. After incubation with 5 ng/ml of NT-4, even later catagen stages (catagen VI) were promoted (mean±SEM, n=8-10 biopsies per group; asterisks indicate significant differences to the control, *P<0.05; **P < 0.01). B–D) Representative examples of skin biopsies cultured with BDNF or NT-4. Organ cultured control skin fragments showed primarily follicles in catagen I or II (B, arrow and arrowhead, respectively) with shrunken yet elongated dermal papillae, surrounded by numerous hair matrix KCs (46 , 53 , 70 ). Instead, a predominance of catagen III (C, arrow) and catagen IV HFs (C, arrowheads), whose hair bulb has already shrunk and whose dermal papilla has acquiesced into a rounded shape, were seen in skin fragments incubated with 0.5 ng/ml of BDNF. Catagen V-VI HFs (D, arrows) appeared after incubation with 5 ng/ml of NT-4. Abbreviations: EP, epidermis; DER, dermis; PCM, panniculus carnosus muscle; SC, subcutis. Scale bars: 100 µm.


   DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
We show here that the hair follicle is both a source and target of neurotrophins. We have characterized the localization of BDNF, NT-4, and TrkB expression in murine HF and have revealed substantial hair cycle-dependent changes in BDNF, NT-4, and TrkB expression, all of which peak during spontaneous HF regression. By analyzing mouse mutants and by skin organ culture studies, we present functional evidence that BDNF and NT-4 accelerate catagen development. This corresponds well to the up-regulation of BDNF, NT-4, and TrkB observed duringcatagen. Even though none of these neurotrophins are absolutely essential for catagen development, since even BDNF or NT-4 knockout mice display only fairly discrete catagen abnormalities, our data suggest that BDNF and NT-4 rank among the elusive factors that control HF regression (catagen) (44 , 82 , 83 ).

Although the underlying mechanisms of action remain to be dissected definitively in future studies, stimulation of the HF anagen-catagen transition by BDNF and NT-4 might be achieved via neurotrophin interaction with dermal papilla fibroblasts. These key elements of hair cycle control (72 , 85 ) strongly express TrkB receptors (Fig. 4C, D ) during the initiation of catagen, whereas hair matrix KCs produce potential ligands (i.e., express BDNF and NT-4 protein) (Fig. 2G–I ). This may result in a down-regulation of papilla-derived growth factors that normally stimulate hair matrix keratinocyte proliferation and suppress KC apoptosis in the HF (44 , 46 ), thus contributing to catagen induction.

During further catagen progression, BDNF and NT-4 may directly regulate the apoptosis and/or survival in those HF KCs that express TrkB receptors in the regressing epithelial strand and the secondary hair germ (Fig. 4E, F ). In the secondary hair germ, a unique HF compartment characterized by the predominance of Bcl-2- over Bax-IR, even during catagen (46) , TrkB-IR is often colocalized with Bcl-2-IR; no coexpression of TrkB-IR and TUNEL was observed here (Fig. 4J, K ). This suggests that TrkB and Bcl-2 double-positive cells in the secondary hair germ of catagen VI HFs might represent KCs, which are selected for survival during the catagen-telogen transformation (46 , 86 ).

Since catagen is essentially an apoptosis-driven phenomenon of organ regression (46) , our findings appear to contrast with numerous publications that have shown BDNF to prevent apoptosis and promote survival in many neuronal model systems (22 , 87-91 ). In fact, it has recently been shown that another member of the neurotrophin family, NGF, can suppress apoptosis in KCs, possibly via interacting with TrkA receptors and subsequent up-regulation of Bcl-2 (12) . BDNF often is coexpressed with TrkB in KCs of the secondary hair germ during catagen (Fig. 4G ), and coexpression of Trk receptors and p75NTR can enhance the anti-apoptotic effects of neurotrophins (76 , 77 , 92 ). In addition, someTrkB-IR KCs in the secondary hair germ also coexpress p75NTR (Fig. 4I ). Therefore, it is tempting to speculate that during later stages of catagen development, BDNF indeed acts as a survival factor for selected, individual KCs in the secondary hair germ.

In contrast, in the epithelial strand, which is a substantially larger regressing HF compartment than the secondary hair germ, single TUNEL+ KCs coexpress TrkB (Fig. 4K ). Also, numerous TrkB-positive cells in the epithelial strand are Bcl-2-IR (Fig. 4J ) but, in contrast to the secondary hair germ, do not coexpress p75NTR (Fig. 4I ). Therefore, BDNF (and possibly NT-4) may serve to induce or up-regulate apoptosis in the epithelial strand, whose rate of apoptosis appears to determine the speed of catagen development (46) . This concept of dual neurotrophin functions in different HF compartments is in line with recent findings that NGF and BDNF, which are primarily appreciated for their anti-apoptotic properties (24 , 25 , 88 ), can also induce apoptosis in several systems via interaction with p75NTR (73-76 , 80 ). Since NGF is even capable of inducing apoptosis in medulloblastoma cells via stimulation of TrkA (78 , 93 , 94 ), it should be considered that BDNF and NT-4 may operate as proapoptotic signals for epithelial strand KCs during catagen. Whether apoptosis in individual KCs of the regressing HF is stimulated by BDNF or NT-4 not only varies among follicular KC subpopulations, but most likely also depends on the local concentration of neurotrophins and the receptor expression pattern, namely, the coexpression of Trk and p75NTR on the target cells (76 , 77 , 79 ).

Until the molecular mechanisms of catagen acceleration of by BDNF and NT-4 have been clarified, it is probably wise to operate on the working hypothesis that BDNF- NT-4/TrkB signaling is just one element in the intrinsic `clock' that determines the switch-on of catagen as the net result of multiple (catagen-promoting and -suppressing) factors (for discussion, see ref 44 ).

Clearly, catagen develops even in the absence of BDNF and NT-4 gene products (Figs. 5, 6) . Yet even a mere fine-tuning role of these neurotrophins in catagen control would be of profound clinical interest, since most hair growth disorders seen in clinical practice (effluvium, alopecia, hypertrichosis, and hirsutism) essentially reflect or involve abnormalities in the time course of anagen termination/catagen initiation (44) . Therefore, TrkB receptor agonists and antagonists deserve to be systematically explored as novel hair growth-modulatory agents for the treatment of common hair growth disorders. Together, the roles of BDNF and NT-4 in hair cycle control described here offer intriguing new perspectives to developmental biologists, clinicians, and industry alike and call for a systematic evaluation of neurotrophins as regulators of epithelial tissue remodeling, since it can be studied in an exemplary manner in the HF (13 , 14 , 16 , 44 , 98 ).


   ACKNOWLEDGMENTS
 
The excellent technical assistance of R. Pliet, C. van der Veen, R. Böhmer, and A. Scheer, riboprobe preparation by A. Mannsfeldt, and the help of M. Ünalan with generation of the graphs are gratefully acknowledged. This study was supported in part by grants from Deutsche Forschungsgemeinschaft (Pa 345/6–1) and Wella AG to R.P.


   FOOTNOTES
 
1 Correspondence: Department of Dermatology, Charité, Humboldt-Universität zu Berlin, Schumannstrasse 20/21, D-10117, Berlin, Germany. E-mail: ralf.paus{at}charite.de

2 Abbreviations: BDNF, brain-derived neurotrophic factor; ELISA, enzyme-linked immunoassay; HF, hair follicle; Ig, immunoglobulin; IR, immunoreactive or immunoreactivity; IRS, inner root sheath; ISH, in situ hybridization; KC, keratinocyte; NGF, nerve growth factor; NT, neurotrophin; NT-3, neurotrophin-3; NT-4, neurotrophin-4; ORS, outer root sheath; P, postnatal day; p75NTR, p75 low-affinity neurotrophin receptor; p.d., depilation; RT-PCR, reverse transcriptase-polymerase chain reaction; TdT, terminal deoxynucleotidyl transferase; TrkA, B, C, tyrosine kinase A, B, C (high-affinity neurotrophin receptors).

Received for publication April 15, 1998. Revision received October 2, 1998.
   REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 

  1. Sariola H., Saarma M., Sainio K., Arumae U., Palgi J., Vaahtokari A., Thesleff I., Karavanov A.. Dependence of kidney morphogenesis on the expression of nerve growth factor receptor. Science 1991;254:571-573.[Abstract/Free Full Text]
  2. Donovan M. J., Hahn R., Tessarollo L., Hempstead B. L.. Identification of an essential nonneuronal function of neurotrophin 3 in mammalian cardiac development. Nature Genet 1996;14:210-213.[Medline]
  3. Huber L. J., Hempstead B., Donovan M. J.. Neurotrophin and neurotrophin receptors in human fetal kidney. Dev. Biol. 1996;179:369-381.[Medline]
  4. Luukko K., Moshnyakov M., Sainio K., Saarma M., Sariola H., Thesleff I.. Expression of neurotrophin receptors during rat tooth development is developmentally regulated, independent of innervation, and suggests functions in the regulation of morphogenesis and innervation. Dev. Dynam. 1996;206:87-99.[Medline]
  5. Luukko K., Arumae U., Karavanov A., Moshnyakov M., Sainio K., Sariola H., Saarma M., Thesleff I.. Neurotrophin mRNA expression in the developing tooth suggests multiple roles in innervation and organogenesis. Dev. Dynam. 1997;210:117-129.[Medline]
  6. Nosrat C. A., Fried K., Lindskog S., Olson L.. Cellular expression of neurotrophin mRNA during tooth development. Cell Tissue Res 1997;290:569-580.[Medline]
  7. Crowley C., Spencer S. D., Nishimura M. C., Chen K. S., Peets-Meek S., Armanini M. P., Ling L. H., McMahon S. B., Shelton D. L., Levinson A. D.. Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell 1994;76:1001-1011.[Medline]
  8. Albers K. M., Wright D. E., Davis B. M.. Overexpression of nerve growth factor in epidermis of transgenic mice causes hypertrophy of the peripheral nervous system. J. Neurosci. 1994;14:1422-1432.[Abstract]
  9. Di Marco E., Marchisio P. C., Bondanza S., Franzi A. T., Cancedda R., De Luca M.. Growth-regulated synthesis and secretion of biologically active nerve growth factor by human keratinocytes. J. Biol. Chem. 1991;266:21718-21722.[Abstract/Free Full Text]
  10. Paus R., Lüftl M., Czarnetzki B. M.. Nerve growth factor modulates keratinocyte proliferation in murine skin organ culture. Br. J. Dermatol. 1994;130:174-180.[Medline]
  11. Pincelli C., Yaar M.. Nerve growth factorits significance in cutaneous biology. J. Invest. Dermatol. Symp. Proc. 1997;2:61-68.
  12. Pincelli C., Haake A. R., Benassi L., Grassilli E., Magoni C., Ottani D., Polakowska R., Franceschi C., Gianetti A.. Autocrine nerve growth factor protects human keratinocytes from apoptosis through its high affinity receptor (Trk)a role for Bcl-2. J. Invest. Dermatol. 1997;109:757-764.[Medline]
  13. Hardy M. H.. The secret life of the hair follicle. Trends Genet 1992;8:55-61.[Medline]
  14. Stenn K. S., Combates N. J., Eilertsen K. J., Gordon J. S., Pardinas J. R., Paromoo S., Prouty S. M.. Hair follicle growth control. Dermatol. Clin. 1996;14:543-557.[Medline]
  15. Peus D., Pittelkow M. R.. Growth factors in hair organ development and the hair growth cycle. Dermatol. Clin. 1996;4:559-572.
  16. Philpott M. F., Paus R.. Principles of hair follicle morphogenesis. Chuong C. M. eds. Molecular Basis of Epithelial Appendage Morphogenesis 1998:75-110 R. G. Landis Co Austin, Texas. .
  17. Botchkarev V. A., Botchkareva N. V., Albers K. M., Lewin G. R., van der Veen C., Paus R.. Neurotrophin-3 involvement in the regulation of hair follicle morphogenesis. J. Invest. Dermatol. 1998;111:279-285.[Medline]
  18. Barde Y. A., Edgar D., Thoenen H.. Purification of a new neurotrophic factor from mammalian brain. EMBO J 1982;1:549-553.[Medline]
  19. Ip N. Y., Ibanez C. F., Nye S. H., McClain J., Jones P. F., Gies D. R., Belluscio L., Le Beau M. M., Espinosa R. D., Squinto S. P.. Mammalian neurotrophin-4structure, chromosomal localization, tissue distribution, and receptor specificity. Proc. Natl. Acad. Sci. USA 1992;89:3060-3064.[Abstract/Free Full Text]
  20. Klein R., Nanduri V., Jing S.A., Lamballe F., Tapley P., Bryant S., Cordon Cardo C., Jones K. R., Reichardt L. F., Barbacid M.. The trkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3. Cell 1991;66:395-403.[Medline]
  21. Klein R., Lamballe F., Bryant S., Barbacid M.. The trkB tyrosine protein kinase is a receptor for neurotrophin-4. Neuron 1992;8:947-956.[Medline]
  22. Klein R.. Role of neurotrophins in mouse neuronal development. FASEB J 1994;8:738-744.[Abstract]
  23. Ibanez C. F.. Neurotrophin 4the odd one out in the neurotrophin family. Neurochem. Res. 1996;21:787-793.[Medline]
  24. Lewin G. R., Barde Y. A.. Physiology of the neurotrophins. Annu. Rev. Neurosci. 1996;19:289-317.[Medline]
  25. Bothwell M.. Neurotrophin function in skin. J. Invest. Dermatol. Symp. Proc. 1997;2:27-30.
  26. Hefti F.. Pharmacology of neurotrophic factors. Annu. Rev. Pharmacol. Toxicol. 1997;37:239-267.[Medline]
  27. Ernfors P., Lee K. F., Jaenisch R.. Mice lacking brain-derived neurotrophic factor develop with sensory deficits. Nature (London) 1994;368:147-150.[Medline]
  28. Korte M., Carroll P., Wolf E., Brem G., Thoenen H., Bonhoeffer T.. Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc. Natl. Acad. Sci. USA 1995;92:8856-8860.[Abstract/Free Full Text]
  29. Fundin B. T., Silos-Santiago I., Ernfors P., Fagan A. M., Aldskogius H., DeChiara T. M., Phillips H., Barbacid M., Yancopoulos G. D., Rice F. L.. Differential dependency of cutaneous mechanoreceptors on neurotrophins, trk receptors, and P75 LNGFR. Dev. Biol. 1997;190:94-116.[Medline]
  30. Rice F. L., Albers K. M., Davis B. M., Silos-Santiago I., Wilkinson G. A., LeMaster A. M., Ernfors P., Smeyne R. J., Aldskogius H., DeChiara T. M.. Differential dependency of unmyelinated and A{delta} epidermal and upper dermal innervation on neurotrophins, trk receptors and p75LNGFR. Dev. Biol. 1998;198:57-81.[Medline]
  31. Botchkarev V. A., Botchkareva N. V., Lommatsch M., Peters E. M. J., Lewin G. R., Subramaniam A., Braun A., Renz H., Paus R.. BDNF overexpression induces differential increases among subsets of sympathetic innervation in murine back skin. Eur. J. Neurosci. 1998;10:3276-3282.[Medline]
  32. Lewin G. R.. Neurotrophins and the specification of neuronal phenotype. Philos. Trans. Roy. Soc. Lond. Ser. B Biol. Sci. 1996;351:405-411.
  33. Carroll P., Lewin G. R., Koltzenburg M., Toyka K., Thoenen H.. A role for BDNF in mechanosensation. Nature Neurosci 1998;1:42-46.[Medline]
  34. Conover J. C., Erickson J. T., Katz D. M., Bianchi L. M., Poueymirou W. T., McClain J., Pan L., Helgren M., Ip N. Y., Boland P.. Neuronal deficits, not involving motor neurons, in mice lacking BDNF and/or NT-4. Nature (London) 1995;375:235-238.[Medline]
  35. Liu X., Ernfors P., Wu H., Jaenisch R.. Sensory but not motor neuron deficits in mice lacking NT-4 and BDNF. Nature (London) 1995;375:238-241.[Medline]
  36. Stucky C. L., DeChiara T., Lindsay R. M., Yancopoulos G. D., Koltzenburg M.. Neurotrophin 4 is required for the survival of a subclass of hair follicle receptors. J. Neurosci. 1998;18:7040-7046.[Abstract/Free Full Text]
  37. Minichiello L., Casagranda F., Tatche R. S., Stucky C. L., Postigo A., Lewin G. R., Davies A. M., Klein R.. Point mutation in trkB causes loss of NT-4-dependent neurons without major effects on diverse BDNF responses. Neuron 1998;21:335-345.[Medline]
  38. Ernfors P., Merlio J.-P., Persson H.. Cells expressing mRNA for neurotrophins and their receptors during embryonic rat development. Eur. J. Neurosci. 1992;4:1140-1158.[Medline]
  39. Ibanez C. F., Ernfors P., Timmusk T., Ip N. Y., Arenas E., Yancopoulos G. D., Persson H.. Neurotrophin-4 is a target-derived neurotrophic factor for neurons of the trigeminal ganglion. Development 1993;117:1345-1353.[Abstract]
  40. Timmusk T., Belluardo N., Metsis M., Persson H.. Widespread and developmentally regulated expression of neurotrophin-4 mRNA in rat brain and peripheral tissues. Eur. J. Neurosci. 1993;5:605-613.[Medline]
  41. Acheson A., Barker P. A., Alderson R. F., Miller F. D., Murphy R. A.. Detection of brain-derived neurotrophic factor-like activity in fibroblasts and Schwann cellsinhibition by antibodies to NGF. Neuron 1991;7:265-275.[Medline]
  42. Bronzetti E., Ciraco E., Germana G., Vega J. A.. Immunocytochemical localization of neurotrophin receptor proteins in human skin. Ital. J. Anat. Embryol (Suppl. 1) 1996;100:565-571.
  43. Shibayama E., Koizumi H.. Cellular localization of the Trk neurotrophin receptor family in human non-neuronal tissues. Am. J. Pathol. 1996;148:1807-1818.[Abstract]
  44. Paus R.. Control of the hair cycle and hair diseases as cycling disorders. Curr. Opin. Dermatol. 1996;3:248-258.
  45. Paus R., Peters E. M. J., Eichmüller S., Botchkarev V. A.. Neural mechanisms of hair growth control. J. Invest. Dermatol. Symp. Proc. 1997;2:61-68.
  46. Lindner G., Botchkarev V. A., Botchkareva N. V., Ling G., van der Veen C., Paus R.. Analysis of apoptosis during hair follicle regression (catagen). Am. J. Pathol. 1997;151:1601-1617.[Abstract]
  47. Paus R., Stenn K. S., Link R. E.. Telogen skin contains an inhibitor of hair growth. Br. J. Dermatol 1990;122:777-784.[Medline]
  48. Li L., Paus R., Slominski A., Hoffman R. M.. Skin histoculture assay for studying the hair cycle. In Vitro Cell Dev. Biol. 1992;28:695-698.
  49. Albers K. M., Perrone T. N., Goodness T. P., Jones M. E., Green M. A., Davis B. M.. Cutaneous overexpression of NT-3 increases sensory and sympathetic neuron number and enhances touch dome and hair follicle innervation. J. Cell Biol. 1996;134:487-497.[Abstract/Free Full Text]
  50. Subramaniam A., Jones W. K., Gulick J., Wert S., Neumann J., Robbins J.. Tissue specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice. J. Biol. Chem. 1991;266:24613-24620.[Abstract/Free Full Text]
  51. Bredman J., Weijs W., Korfage H. A. M., Brugman P., Moorman A. F. M.. Myosin heavy chain expression in rabbit masseter muscle during postnatal development. J. Anat. 1992;180:263-274.
  52. Chase H. B.. Growth of the hair. Physiol. Rev. 1954;34:113-126.[Free Full Text]
  53. Paus R., Handjiski B., Czarnetzki B. M., Eichmüller S.. A murine model for inducing and manipulating hair follicle regression (catagen)effects of dexamethasone and cyclosporin A. J. Invest. Dermatol. 1994;103:143-147.[Medline]
  54. Paus R., Hofmann U., Eichmüller S., Czarnetzki B. M.. Distribution and changing density of gamma-delta T cells in murine skin during the induced hair cycle. Br. J. Dermatol. 1994;130:281-289.[Medline]
  55. Nakanishi T., Takahashi K., Aoki C., Nishikawa K., Hattori T., Taniguchi S.. Expression of nerve growth factor family neurotrophins in a mouse osteoblastic cell line. Biochem. Biophys. Res. Commun. 1994;198:891-897.[Medline]
  56. Suter-Crazzolara C., Lachmund A., Arab S. F., Unsicker K.. Expression of neurotrophins and their receptors in the developing and rat adrenal gland. Mol. Brain Res. 1996;43:351-355.[Medline]
  57. Pethö-Schramm A., Müller H.-J., Paus R.. FGF5 and the murine hair cycle. Arch. Dermatol. Res. 1996;288:264-266.[Medline]
  58. Welker P., Foitzik K., Bulfone-Paus S., Henz B. M., Paus R.. Hair cycle-dependent changes in the gene expression and protein content of transforming growth factor beta1 and beta3 in murine skin. Arch. Dermatol. Res. 1997;289:554-557.[Medline]
  59. Panteleyev A., Paus R., Wanner R., Nurnberg W., Eichmüller S., Thiel R., Zhang J., Henz B. M., Rosenbach T.. Keratin 17 gene expression during the murine hair cycle. J. Invest. Dermatol. 1997;108:324-329.[Medline]
  60. Hofer M., Pagliusi S. R., Hohn A., Leibrock J., Barde, Y.-A. Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain. EMBO J 1990;9:2459-2462.[Medline]
  61. Persson H., Ernfors P.. Visualization and quantification off neurotrophin mRNAs. Boulton G. B. A. Hefti F. eds. NeuromethodsNeurotrophic Factors 1993;Vol. 25:57-106 Humana Press Totowa, N.J.. .
  62. Klein R., Conway D., Parada L. F., Barbacid M.. The trkB tyrosine protein kinase gene codes for a second neurogenic receptor that lacks the catalytic kinase domain. Cell 1990;61:647-656.[Medline]
  63. Botchkarev V. A., Eichmüller S., Johansson O., Paus R.. Hair cycle-dependent plasticity of skin and hair follicle innervation in normal murine skin. J. Comp. Neurol. 1997;386:379-395.[Medline]
  64. Botchkarev V. A., Eichmüller S., Peters E. M. J., Pietsch P., Johansson O., Maurer M., Paus R.. A simple fluorescent technique for covisualization of mast cells an